BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28570866)

  • 1. Differentiated effects of deep brain stimulation and medication on somatosensory processing in Parkinson's disease.
    Sridharan KS; Højlund A; Johnsen EL; Sunde NA; Johansen LG; Beniczky S; Østergaard K
    Clin Neurophysiol; 2017 Jul; 128(7):1327-1336. PubMed ID: 28570866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DBS on auditory and somatosensory processing in Parkinson's disease.
    Airaksinen K; Mäkelä JP; Taulu S; Ahonen A; Nurminen J; Schnitzler A; Pekkonen E
    Hum Brain Mapp; 2011 Jul; 32(7):1091-9. PubMed ID: 20645306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered somatosensory processing in Parkinson's disease and modulation by dopaminergic medications.
    Nelson AJ; Hoque T; Gunraj C; Chen R
    Parkinsonism Relat Disord; 2018 Aug; 53():76-81. PubMed ID: 29764720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus stimulation and somatosensory temporal discrimination in Parkinson's disease.
    Conte A; Modugno N; Lena F; Dispenza S; Gandolfi B; Iezzi E; Fabbrini G; Berardelli A
    Brain; 2010 Sep; 133(9):2656-63. PubMed ID: 20802206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus deep brain stimulation improves somatosensory function in Parkinson's disease.
    Aman JE; Abosch A; Bebler M; Lu CH; Konczak J
    Mov Disord; 2014 Feb; 29(2):221-8. PubMed ID: 24243788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
    Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease.
    Angeli A; Akram H; Zacharia A; Limousin P; Hariz M; Zrinzo L; Foltynie T
    Parkinsonism Relat Disord; 2015 Jun; 21(6):597-602. PubMed ID: 25842261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation improves survival in severe Parkinson's disease.
    Ngoga D; Mitchell R; Kausar J; Hodson J; Harries A; Pall H
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):17-22. PubMed ID: 23843542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pallidal deep brain stimulation and L-dopa do not improve qualitative aspects of skilled reaching in Parkinson's disease.
    Melvin KG; Doan J; Pellis SM; Brown L; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2005 May; 160(1):188-94. PubMed ID: 15836914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.
    Hacker ML; Tonascia J; Turchan M; Currie A; Heusinkveld L; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Wang L; Shi Y; Shade DM; Sternberg AL; Drye LT; Charles D
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1177-83. PubMed ID: 26306000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
    Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
    Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
    Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
    J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.